ID   CD5R1_MOUSE             Reviewed;         307 AA.
AC   P61809; Q62938;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 1.
DT   18-JUN-2025, entry version 176.
DE   RecName: Full=Cyclin-dependent kinase 5 activator 1;
DE            Short=CDK5 activator 1;
DE   AltName: Full=Cyclin-dependent kinase 5 regulatory subunit 1;
DE   AltName: Full=TPKII regulatory subunit;
DE   Contains:
DE     RecName: Full=Cyclin-dependent kinase 5 activator 1, p35;
DE              Short=p35;
DE   Contains:
DE     RecName: Full=Cyclin-dependent kinase 5 activator 1, p25;
DE              Short=p25;
DE     AltName: Full=Tau protein kinase II 23 kDa subunit;
DE              Short=p23;
DE   Flags: Precursor;
GN   Name=Cdk5r1; Synonyms=Cdk5r, Nck5a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=129/Sv;
RA   Nilden F., Backstrom A., Bark I.C.;
RT   "Differential mRNA expression of the CDK5 activators P35 and P39 in the
RT   developing mouse brain.";
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=129/SvJ; TISSUE=Brain;
RX   PubMed=8661152; DOI=10.1006/geno.1996.0370;
RA   Ohshima T., Kozak C.A., Nagle J.W., Pant H.C., Brady R.O., Kulkarni A.B.;
RT   "Molecular cloning and chromosomal mapping of the mouse gene encoding
RT   cyclin-dependent kinase 5 regulatory subunit p35.";
RL   Genomics 35:372-375(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEOLYTIC CLEAVAGE BY CALPAIN.
RX   PubMed=10830966; DOI=10.1038/35012636;
RA   Lee M.-S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.-H.;
RT   "Neurotoxicity induces cleavage of p35 to p25 by calpain.";
RL   Nature 405:360-364(2000).
RN   [5]
RP   INTERACTION WITH CDK5; CDK5RAP1; CDK5RAP2 AND CDK5RAP3, AND MUTAGENESIS OF
RP   GLU-157.
RX   PubMed=11882646; DOI=10.1074/jbc.c200032200;
RA   Ching Y.-P., Pang A.S.H., Lam W.-H., Qi R.Z., Wang J.H.;
RT   "Identification of a neuronal Cdk5 activator-binding protein as Cdk5
RT   inhibitor.";
RL   J. Biol. Chem. 277:15237-15240(2002).
RN   [6]
RP   FUNCTION IN DENDRITIC SPINE MORPHOGENESIS, INTERACTION WITH NGEF, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17143272; DOI=10.1038/nn1811;
RA   Fu W.Y., Chen Y., Sahin M., Zhao X.S., Shi L., Bikoff J.B., Lai K.O.,
RA   Yung W.H., Fu A.K., Greenberg M.E., Ip N.Y.;
RT   "Cdk5 regulates EphA4-mediated dendritic spine retraction through an
RT   ephexin1-dependent mechanism.";
RL   Nat. Neurosci. 10:67-76(2007).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH CLOCK.
RX   PubMed=24235147; DOI=10.1074/jbc.m113.494856;
RA   Kwak Y., Jeong J., Lee S., Park Y.U., Lee S.A., Han D.H., Kim J.H.,
RA   Ohshima T., Mikoshiba K., Suh Y.H., Cho S., Park S.K.;
RT   "Cyclin-dependent kinase 5 (Cdk5) regulates the function of CLOCK protein
RT   by direct phosphorylation.";
RL   J. Biol. Chem. 288:36878-36889(2013).
CC   -!- FUNCTION: p35 is a neuron specific activator of CDK5. The complex
CC       p35/CDK5 is required for neurite outgrowth and cortical lamination.
CC       Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4
CC       signaling. Activator of TPKII. The complex p35/CDK5 participates in the
CC       regulation of the circadian clock by modulating the function of CLOCK
CC       protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates
CC       the transcriptional activity of the CLOCK-BMAL1 heterodimer in
CC       association with altered stability and subcellular distribution.
CC       {ECO:0000269|PubMed:17143272, ECO:0000269|PubMed:24235147}.
CC   -!- SUBUNIT: Heterodimer composed of a catalytic subunit CDK5 and a
CC       regulatory subunit CDK5R1 (p25) and macromolecular complex composed of
CC       at least CDK5, CDK5R1 (p35) and CDK5RAP1 or CDK5RAP2 or CDK5RAP3
CC       (PubMed:11882646). Only the heterodimer shows kinase activity
CC       (PubMed:11882646). Interacts with EPHA4 and NGEF; may mediate the
CC       activation of NGEF by EPHA4 (PubMed:17143272). Interacts with RASGRF2.
CC       The complex p35/CDK5 interacts with CLOCK (PubMed:24235147).
CC       {ECO:0000269|PubMed:11882646, ECO:0000269|PubMed:17143272,
CC       ECO:0000269|PubMed:24235147}.
CC   -!- INTERACTION:
CC       P61809; P09803: Cdh1; NbExp=2; IntAct=EBI-7840438, EBI-984420;
CC       P61809; P49615: Cdk5; NbExp=4; IntAct=EBI-7840438, EBI-6510052;
CC       P61809; Q80U04: Pja2; NbExp=2; IntAct=EBI-7840438, EBI-1801691;
CC       P61809; Q8CFH6: Sik2; NbExp=3; IntAct=EBI-7840438, EBI-16094102;
CC   -!- SUBCELLULAR LOCATION: [Cyclin-dependent kinase 5 activator 1, p35]:
CC       Cell membrane {ECO:0000250|UniProtKB:Q15078}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q15078}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q15078}. Cell projection, neuron projection
CC       {ECO:0000250|UniProtKB:Q15078}. Note=In the primary cortical neurons,
CC       p35 is present in the peripheries and nerve terminals.
CC       {ECO:0000250|UniProtKB:Q15078}.
CC   -!- SUBCELLULAR LOCATION: [Cyclin-dependent kinase 5 activator 1, p25]:
CC       Nucleus {ECO:0000250|UniProtKB:Q15078}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:Q15078}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q15078}. Note=The conversion of p35 to p25
CC       relocalizes the protein from the cell periphery to the cytoplasm, in
CC       nuclear and perinuclear regions. In the primary cortical neurons, p25
CC       is primarily concentrated in the cell soma and is largely absent from
CC       neurites. {ECO:0000250|UniProtKB:Q15078}.
CC   -!- TISSUE SPECIFICITY: Brain and neuron specific.
CC   -!- PTM: The p35 form is proteolytically cleaved by calpain, giving rise to
CC       the p25 form. P35 has a 5 to 10 fold shorter half-life compared to p25.
CC       The conversion results in deregulation of the CDK5 kinase: p25/CDK5
CC       kinase displays an increased and altered tau phosphorylation in
CC       comparison to the p35/CDK5 kinase in vivo.
CC       {ECO:0000269|PubMed:10830966}.
CC   -!- PTM: Myristoylated. A proper myristoylation signal is essential for the
CC       proper distribution of p35 (By similarity).
CC       {ECO:0000250|UniProtKB:Q15078}.
CC   -!- PTM: Phosphorylation at Ser-8 and Thr-138 by CDK5 prevents calpain-
CC       mediated proteolysis. {ECO:0000250|UniProtKB:Q15078}.
CC   -!- PTM: Ubiquitinated, leading to its degradation: degradation of p35 by
CC       proteasome results in down-regulation of CDK5 activity. During this
CC       process, CDK5 phosphorylates p35 and induces its ubiquitination and
CC       subsequent degradation. Ubiquitinated by the CRL2(FEM1B) complex, which
CC       recognizes the -Gly-Leu-Asp-Arg C-degron at the C-terminus, leading to
CC       its degradation. {ECO:0000250|UniProtKB:Q15078}.
CC   -!- SIMILARITY: Belongs to the cyclin-dependent kinase 5 activator family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U89527; AAB49474.1; -; mRNA.
DR   EMBL; Y11335; CAA72176.1; -; Genomic_DNA.
DR   EMBL; S82819; AAB46777.1; -; Genomic_DNA.
DR   EMBL; BC046823; AAH46823.1; -; mRNA.
DR   EMBL; BC050768; AAH50768.1; -; mRNA.
DR   EMBL; BC058697; AAH58697.1; -; mRNA.
DR   CCDS; CCDS25134.1; -.
DR   RefSeq; NP_034001.1; NM_009871.3.
DR   AlphaFoldDB; P61809; -.
DR   SMR; P61809; -.
DR   BioGRID; 198647; 6.
DR   ComplexPortal; CPX-3143; Cyclin-dependent protein kinase 5 holoenzyme complex, p35 variant.
DR   ComplexPortal; CPX-3144; Cyclin-dependent protein kinase 5 holoenzyme complex, p25 variant.
DR   CORUM; P61809; -.
DR   DIP; DIP-29354N; -.
DR   FunCoup; P61809; 975.
DR   IntAct; P61809; 7.
DR   MINT; P61809; -.
DR   STRING; 10090.ENSMUSP00000099514; -.
DR   ChEMBL; CHEMBL3885555; -.
DR   GlyGen; P61809; 1 site.
DR   iPTMnet; P61809; -.
DR   PhosphoSitePlus; P61809; -.
DR   PaxDb; 10090-ENSMUSP00000099514; -.
DR   ProteomicsDB; 280026; -.
DR   Antibodypedia; 15411; 279 antibodies from 34 providers.
DR   DNASU; 12569; -.
DR   Ensembl; ENSMUST00000053413.12; ENSMUSP00000099514.5; ENSMUSG00000048895.14.
DR   GeneID; 12569; -.
DR   KEGG; mmu:12569; -.
DR   UCSC; uc007kmg.1; mouse.
DR   AGR; MGI:101764; -.
DR   CTD; 8851; -.
DR   MGI; MGI:101764; Cdk5r1.
DR   VEuPathDB; HostDB:ENSMUSG00000048895; -.
DR   eggNOG; KOG3932; Eukaryota.
DR   GeneTree; ENSGT00390000008812; -.
DR   HOGENOM; CLU_034132_2_0_1; -.
DR   InParanoid; P61809; -.
DR   OMA; QHCNQNQ; -.
DR   OrthoDB; 7676799at2759; -.
DR   PhylomeDB; P61809; -.
DR   Reactome; R-MMU-399956; CRMPs in Sema3A signaling.
DR   Reactome; R-MMU-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   BioGRID-ORCS; 12569; 3 hits in 81 CRISPR screens.
DR   CD-CODE; CE726F99; Postsynaptic density.
DR   ChiTaRS; Cdk5r1; mouse.
DR   PRO; PR:P61809; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; P61809; protein.
DR   Bgee; ENSMUSG00000048895; Expressed in rostral migratory stream and 195 other cell types or tissues.
DR   ExpressionAtlas; P61809; baseline and differential.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0043292; C:contractile muscle fiber; ISS:UniProtKB.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0016533; C:protein kinase 5 complex; IPI:ComplexPortal.
DR   GO; GO:0003779; F:actin binding; IPI:ARUK-UCL.
DR   GO; GO:0051015; F:actin filament binding; IPI:ARUK-UCL.
DR   GO; GO:0045296; F:cadherin binding; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0061575; F:cyclin-dependent protein serine/threonine kinase activator activity; IMP:MGI.
DR   GO; GO:0008092; F:cytoskeletal protein binding; TAS:MGI.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0016301; F:kinase activity; ISS:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:ARUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IMP:UniProtKB.
DR   GO; GO:0007413; P:axonal fasciculation; IMP:UniProtKB.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0021549; P:cerebellum development; IMP:MGI.
DR   GO; GO:0021799; P:cerebral cortex radially oriented cell migration; IMP:DFLAT.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007213; P:G protein-coupled acetylcholine receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070315; P:G1 to G0 transition involved in cell differentiation; IMP:MGI.
DR   GO; GO:0021766; P:hippocampus development; IGI:MGI.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0021819; P:layer formation in cerebral cortex; IGI:MGI.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IEA:Ensembl.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; IDA:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IDA:MGI.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IMP:DFLAT.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; IMP:UniProtKB.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IMP:DFLAT.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0021722; P:superior olivary nucleus maturation; IGI:MGI.
DR   FunFam; 1.10.472.10:FF:000025; Cyclin-dependent kinase 5 activator; 1.
DR   Gene3D; 1.10.472.10; Cyclin-like; 1.
DR   InterPro; IPR004944; CDK5_activator.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   PANTHER; PTHR23401; CYCLIN DEPENDANT KINASE-5 ACTIVATOR; 1.
DR   PANTHER; PTHR23401:SF2; CYCLIN-DEPENDENT KINASE 5 ACTIVATOR 1; 1.
DR   Pfam; PF03261; CDK5_activator; 1.
DR   PIRSF; PIRSF009324; Cdk5_activator; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 1.
DR   TreeFam; TF101036; -.
PE   1: Evidence at protein level;
KW   Biological rhythms; Cell membrane; Cell projection; Cytoplasm; Lipoprotein;
KW   Membrane; Myristate; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q15078"
FT   CHAIN           2..307
FT                   /note="Cyclin-dependent kinase 5 activator 1, p35"
FT                   /id="PRO_0000004796"
FT   CHAIN           99..307
FT                   /note="Cyclin-dependent kinase 5 activator 1, p25"
FT                   /id="PRO_0000004797"
FT   REGION          97..133
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        100..110
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        112..125
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            98..99
FT                   /note="Cleavage; by calpain"
FT                   /evidence="ECO:0000269|PubMed:10830966"
FT   MOD_RES         8
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:Q15078"
FT   MOD_RES         138
FT                   /note="Phosphothreonine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:Q15078"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         157
FT                   /note="E->Q: Abolishes the binding to CDK5RAP1, CDK5RAP2,
FT                   CDKRAP3, but not to CDK5."
FT                   /evidence="ECO:0000269|PubMed:11882646"
SQ   SEQUENCE   307 AA;  34031 MW;  165AA0747410B0C0 CRC64;
     MGTVLSLSPS YRKATLFEDG AATVGHYTAV QNSKNAKDKN LKRHSIISVL PWKRIVAVSA
     KKKNSKKAQP NSSYQSNIAH LNNENLKKSL SCANLSTFAQ PPPAQPPAPP ASQLSGSQTG
     VSSSVKKAPH PAITSAGTPK RVIVQASTSE LLRCLGEFLC RRCYRLKHLS PTDPVLWLRS
     VDRSLLLQGW QDQGFITPAN VVFLYMLCRD VISSEVGSDH ELQAVLLTCL YLSYSYMGNE
     ISYPLKPFLV ESCKEAFWDR CLSVINLMSS KMLQINADPH YFTQVFSDLK NESGQEDKKR
     LLLGLDR
//
